IMA Total Utang marang Modal ImageneBio Inc

IMA (ikenaoncology.com) - tandha merek perusahaan

This daily price chart for ImageneBio Inc (IMA) on the GURU.Markets platform reflects the 0.03 metric. ImageneBio Inc minimizes capital expenditures by outsourcing oncology drug trials to third-party contractors. A stock option system ensures the stability of the scientific staff, while current hiring focuses on drug delivery experts. However, the lack of consistent profit and fierce sector competition force the business to rely on new equity issuances.

IMA Rasio Kabeh Utang marang Dana Pribadi Ikena Oncology, Inc. (29.07.2025 - 28.10.2026)

Rincian analitis perusahaan ImageneBio Inc

- rega lan prakiraan konsensus rega:
Rega saham ImageneBio|IMA - Konsensus nilai wajar
- data kapitalisasi pasar:
Kapitalisasi pasar Ikena Oncology|IMA - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Ikena Oncology|IMA - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku ikenaoncology.com|IMA - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal ImageneBio Inc|IMA - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas ImageneBio|IMA - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Ikena Oncology|IMA - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Ikena Oncology
Analisis dhasar perusahaan:ImageneBio Inc - IMA
Produk dadi Ikena Oncology, Inc.

For a long-term investor, the reliability of ImageneBio Inc (IMA) is determined by the balance between cancer therapy development costs and the sources used to cover them. This ratio measures the proportion of debt obligations within the equity structure, and analyzing the shift in the debt-to-equity ratio allows for an assessment of the biotech's risk of dependence on external borrowing while seeking strategic partners.

Pesaing wigati

ARGX - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi BioNTech Inc.|Total Utang marang Modal ABVX|Total Utang marang Modal ADMA (ADMA Corp)|Utang marang Ekuitas Protagonist Therapeutics|immunovant.com - Rasio Kabeh Utang marang Dana Pribadi|KNSA: Utang marang Ekuitas|GRFS - Rasio Total Utang marang Ekuitas|ADPT: Total Utang marang Modal|Total Utang marang Modal Celldex Corp|AUPH - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi biocryst.com|VERA (Vera Therapeutics) - Total Utang marang Modal|Koefisien Total Utang marang Modal DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp - Utang marang Ekuitas|AbCellera - Rasio Total Utang marang Ekuitas|TRML: Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|PHAR: Rasio Total Utang marang Ekuitas|NKTR (Nektar Therapeutics Inc) - Total Utang marang Modal|Utang marang Ekuitas Upstream Bio Corp (UPB)|Rasio Utang marang Ekuitas Zenas Corp|Immunome, Inc. - Total Utang marang Modal|Utang marang Modal gossamerbio.com (GOSS)|Total Utang marang Modal KALV|Septerna, Inc. - Koefisien Total Utang marang Modal|PVLA: Utang marang Ekuitas|SVRA - Rasio Total Utang marang Ekuitas|RIGL: Total Utang marang Modal|anaptysbio.com (ANAB) - Total Utang marang Modal|Astria Therapeutics, Inc. - Total Utang marang Modal|Rasio Utang marang Modal enGene Holdings Inc|RAPT Therapeutics, Inc. - Total Utang marang Modal|Utang marang Modal JBIO (aerovatetx.com)|ACRS - Utang marang Ekuitas|Rasio Utang marang Ekuitas kyvernatx.com KYTX|TLSA (Tiziana Life Sciences Ltd) - Total Utang marang Modal|CABA - Utang marang Modal|Ventyx Bio (VTYX) - Total Utang marang Modal|Theratechnologies, Inc (THTX) - Utang marang Ekuitas|AVTX: Total Utang marang Modal|Koefisien Total Utang marang Modal ELDN|Agenus Inc. - Utang marang Ekuitas|Utang marang Modal Climb Bio Inc. CLYM|Rasio Total Utang marang Ekuitas Zura Bio Limited|Rasio Kabeh Utang marang Dana Pribadi aTyr Pharmaceuticals ATYR|Total Utang marang Modal ADAG (Adagene Corp)|STTK: Koefisien Total Utang marang Modal|Utang marang Ekuitas equilliumbio.com|Connect Biopharma Holdings Limited (CNTB) - Rasio Utang marang Ekuitas|Total Utang marang Modal IMUX|Rasio Total Utang marang Ekuitas Atara Biotherapeutics Inc|IFRX (InflaRx N.V.) - Total Utang marang Modal|Koefisien Total Utang marang Modal XFOR (x4pharma.com)|Adicet Bio, Inc. - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celularity Inc CELU|INmune Bio Corp - Total Utang marang Modal|BRNS: Total Utang marang Modal|Utang marang Ekuitas Kezar Life Sciences (KZR)|sabbiotherapeutics.com (SABS) - Utang Agregat marang Ekuitas|AKTX - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Enlivex Therapeutics, Ltd.|Total Utang marang Modal QTTB|Total Utang marang Modal GOVX (GeoVax Corp)|Utang marang Ekuitas Edesa Biotech, Inc.|ibioinc.com - Rasio Kabeh Utang marang Dana Pribadi|CARM: Utang marang Ekuitas|XTLB - Rasio Total Utang marang Ekuitas|BOLT: Total Utang marang Modal|Total Utang marang Modal HCW Biologics|APVO - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi AIM ImmunoTech, Inc.|ADTX (Aditxt) - Total Utang marang Modal|Koefisien Total Utang marang Modal GRI (GRI Bio Inc)|XORTX - Utang marang Ekuitas|Vyome Therapeutics - Rasio Total Utang marang Ekuitas|REVB: Utang marang Ekuitas|indaptusrx.com (INDP) - Rasio Total Utang marang Ekuitas|SCNI: Rasio Total Utang marang Ekuitas|CALI (CalciMedica) - Total Utang marang Modal|Utang marang Ekuitas Affimed NV (AFMD)|Rasio Utang marang Ekuitas Allakos Therapeutics|HOOKIPA Pharma Inc. - Total Utang marang Modal|Utang marang Modal igmbio.com (IGMS)|Total Utang marang Modal ITOS|Ocean Biomedical Inc - Koefisien Total Utang marang Modal|TCBP: Utang marang Ekuitas|THRD - Rasio Total Utang marang Ekuitas